|
1
|
Ke H, Donglin W, Wei L, Lini G and Meixi
C: Analysis of clinical features and ultrasound manifestations of
aggressive fibromatosis. Oncoradiology. 32:59–63. 2023.
|
|
2
|
Min S, Houmei W, Jing Y, Ziwen X and Canli
X: A case of pregnancy complicated with giant abdominal wall
aggressive fibromatosis. Chin J New Clin Med. 18:214–216. 2025.
|
|
3
|
Benech N, Bonvalot S, Dufresne A, Gangi A,
Le Péchoux C, Lopez-Trabada-Ataz D, Meurgey A, Nicolas N, Orbach D,
Penel N, et al: Desmoid tumors located in the abdomen or associated
with adenomatous polyposis: French intergroup clinical practice
guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD,
GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis.
54:737–746. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee JC, Thomas JM, Phillips S, Fisher C
and Moskovic E: Aggressive fibromatosis: MRI features with
pathologic correlation. AJR Am J Roentgenol. 186:247–254.
2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Varghese S, Braggio DA, Gillespie J,
Toland AE, Pollock R, Mayerson J, Scharschmidt T and Iwenofu OH:
TGF-β and CTGF are mitogenic output mediators of Wnt/β-catenin
signaling in desmoid fibromatosis. Appl Immunohistochem Mol
Morphol. 25:559–565. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lee YS, Joo MW, Shin SH, Hong S and Chung
YG: Current treatment concepts for extra-abdominal desmoid-type
fibromatosis: A narrative review. Cancers (Basel).
16(273)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Keping Z, Jie X, Zhihua L, Danyi L and Jie
C: Role of β-catenin expression and gene mutation in diagnosis of
aggressive fibromatosis. Chin J Diagn Pathol. 30:155–157, 161.
2023.
|
|
8
|
von Mehren M, Kane JM, Agulnik M, Bui MM,
Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ,
et al: Soft tissue sarcoma, version 2.2022, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 20:815–833.
2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jin Z, Zhang Q, Tang D, Wang L, Wang W, Xu
M, Li Z and Wang D: Successful treatment of giant mesenteric
fibromatosis with surgery and tamoxifen: case report. Transl Cancer
Res. 8:996–1000. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu X, Zong S, Cui Y and Yue Y:
Misdiagnosis of aggressive fibromatosis of the abdominal wall: A
case report and literature review. Medicine (Baltimore).
97(e9925)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen J, Ye Q and Huang F: Clinical
characteristics, diagnosis and treatment of intra-abdominal
aggressive fibromatosis. China Oncol. 28:622–626. 2018.(In
Chinese).
|
|
12
|
Zhao D and Wang X: A rare cause of small
bowel obstruction caused by duodenum-derived aggressive
fibromatosis with β-catenin T41A mutation: A case analysis.
Medicine (Baltimore). 103(e38984)2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Humphries D, Fritzke T, Pacheco1 F,
Sripathi S, Marcano D and Alashari A: A case report of fibromatosis
resulting in small bowel obstruction. Int J Case Rep Images.
15:15–18. 2024.
|
|
14
|
Wang YK, Jiang B, Yang YC, Wang SN, Li YY,
Meng NL, Yuan XT, Jiang RD and Li ZG: Gastric aggressive
fibromatosis: Report of a case and review of the literature. Int J
Clin Exp Pathol. 12:372–377. 2019.PubMed/NCBI
|
|
15
|
Yang X and Xu Z: Hemorrhagic shock caused
by an aggressive fibromatosis in the gastropancreatic region: A
case report. Case Rep Oncol. 18:436–442. 2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jambhekar A, Robinson S, Zafarani P,
Rucinski J and Gudavalli P: Intestinal obstruction caused by
desmoid tumours: A review of the literature. JRSM Open.
9(2054270418763340)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iordache IE, Alexandrescu L, Nicoara AD,
Popescu R, Leopa N, Baltatescu G, Nelson Twakor A, Tofolean IT and
Steriu L: Twisted troubles: A rare case of intestinal obstruction
due to endometriosis and a review of the literature. Clin Pract.
14:2027–2043. 2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu PP, Liu XC, Yin L and Yin G: Aggressive
fibromatosis of the sigmoid colon: A case report. World J
Gastrointest Oncol. 16:3716–3722. 2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Torres JC and Xin C: An unusual finding in
a desmoid-type fibromatosis of the pancreas: A case report and
review of the literature. J Med Case Rep. 12(123)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kasper B, Baldini EH, Bonvalot S,
Callegaro D, Cardona K, Colombo C, Corradini N, Crago AM, Dei Tos
AP, Dileo P, et al: Current management of desmoid tumors: A review.
JAMA Oncol. 10:1121–1128. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jianmin Z: Clinical and pathological
observations of three cases of ligamentum-like tumors. Shanxi Med
J. 41:459–460. 2012.(In Chinese).
|
|
22
|
Hamada S, Urakawa H, Kozawa E, Arai E,
Ikuta K, Sakai T, Ishiguro N and Nishida Y: Characteristics of
cultured desmoid cells with different CTNNB1 mutation status.
Cancer Med. 5:352–360. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
McLean TD, Duchi S and Di Bella C:
Molecular pathogenesis of sporadic desmoid tumours and its
implications for novel therapies: A systematised narrative review.
Target Oncol. 17:223–252. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jeong E, Ku J, Na JM, Kim W, Sung CO and
Kim SH: Comprehensive RNA sequencing analysis identifies network
hub genes and biomarkers differentiating desmoid-type fibromatosis
from reactive fibrosis. Lab Invest. 105(102204)2025.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gao C, Wang Y, Broaddus R, Sun L, Xue F
and Zhang W: Exon 3 mutations of CTNNB1 drive tumorigenesis: A
review. Oncotarget. 9:5492–5508. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lazar AJ, Tuvin D, Hajibashi S, Habeeb S,
Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D,
Pollock RE and Lev D: Specific mutations in the beta-catenin gene
(CTNNB1) correlate with local recurrence in sporadic desmoid
tumors. Am J Pathol. 173:1518–1527. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xiuwen C, Senyuan L, Xianbin T, Tieyan W,
Li W and Yugang H: Correlation between CTNNB1 gene mutations and
recurrence in aggressive fibromatosis. Chin J Clin Exp Pathol.
37:337–340. 2021.(In Chinese).
|
|
28
|
Dumont AG, Rink L, Godwin AK, Miettinen M,
Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin
BP, et al: A nonrandom association of gastrointestinal stromal
tumor (GIST) and desmoid tumor (deep fibromatosis): Case series of
28 patients. Ann Oncol. 23:1335–1340. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Siaudinyte I, Spiliauskaite S, Arlauskiene
A, Lauzikiene D and Ramasauskaite D: Rapid growth of a giant
intra-abdominal desmoid tumor diagnosed during pregnancy. Am Surg.
85:e204–e207. 2019.PubMed/NCBI
|
|
30
|
Rosa AA, Carolina AP, Marta AV, Francisco
A, Adriana FG, Natalia G, Pablo LL, Cristina MF, Lidia MS, Ulrike
N, et al: Desmoid tumors-experience from a referral center, part 1:
Multidisciplinary review and practical recommendations. Cancers
(Basel). 17(3470)2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Moore D, Burns L, Creavin B, Ryan E,
Conlon K, Kelly ME and Kavanagh D: Surgical management of abdominal
desmoids: A systematic review and meta-analysis. Ir J Med Sci.
192:549–560. 2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Krieg AH, Wirth C, Lenze U, Kettelhack C,
Coslovsky M, Baumhoer D, Klenke FM, Siebenrock KA, Exner GU,
Bode-Lesniewska B, et al: Extra-abdominal desmoid tumours-further
evidence for the watchful waiting policy. Swiss Med Wkly.
149(w20107)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mangla A, Agarwal N and Schwartz G:
Desmoid tumors: Current perspective and treatment. Curr Treat
Options Oncol. 25:161–175. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gounder MM, Mahoney MR, Van Tine BA, Ravi
V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S,
et al: Sorafenib for advanced and refractory desmoid tumors. N Engl
J Med. 379:2417–2428. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Desmoid Tumor Working Group. The
management of desmoid tumours: A joint global consensus-based
guideline approach for adult and paediatric patients. Eur J Cancer.
127:96–107. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Penel N, Kasper B and van Der Graaf WTA:
Desmoid-type fibromatosis: Toward a holistic management. Curr Opin
Oncol. 33:309–314. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Colombo C, Hakkesteegt S, Le Cesne A,
Barretta F, Blay JY, Grünhagen DJ, Penel N, Lam L, Fiore M,
Palassini E, et al: Active surveillance in patients with
extra-abdominal desmoid-type fibromatosis: A pooled analysis of
three prospective observational studies. Clin Cancer Res.
31:603–610. 2025.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lehnhardt M, Weskamp P, Sogorski A,
Reinkemeier F, von Glinski M, Behr B and Harati K: Aggressive
fibromatosis: Retrospective analysis of 110 patients. Handchir
Mikrochir Plast Chir. 55:106–113. 2023.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
39
|
Yu A, Butler Z, Honore L, Unson G,
Demetrious M, Gitelis S, Tasse J and T Blank A: Clinical challenges
and evolving treatments in desmoid fibromatosis: A single
institution experience. Cancer Invest. 43:257–266. 2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Janssen ML, van Broekhoven DLM, Cates JMM,
Bramer WM, Nuyttens JJ, Gronchi A, Salas S, Bonvalot S, Grünhagen
DJ and Verhoef C: Meta-analysis of the influence of surgical margin
and adjuvant radiotherapy on local recurrence after resection of
sporadic desmoid-type fibromatosis. Br J Surg. 104:347–357.
2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hamza WS, Salama MF, Morsi SS, Abdo NM and
Al-Fadhli MA: Benchmarking for surgical site infections among
gastrointestinal surgeries and related risk factors: Multicenter
study in Kuwait. Infect Drug Resist. 11:1373–1381. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Xu Z, Qu H, Kanani G, Guo Z, Ren Y and
Chen X: Update on risk factors of surgical site infection in
colorectal cancer: A systematic review and meta-analysis. Int J
Colorectal Dis. 35:2147–2156. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mulita F, Liolis E, Akinosoglou K,
Tchabashvili L, Maroulis I, Kaplanis C, Vailas M and Panos G:
Postoperative sepsis after colorectal surgery: A prospective
single-center observational study and review of the literature. Prz
Gastroenterol. 17:47–51. 2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zajonz TS, Edinger F, Markmann M, Gräb K,
Sander M, Kunzemann C, Koch C and Schneck E: Optimization of the
cardiac delirium index by including age, decrease in
butyrylcholinesterase actitivity, preoperative HbA1c, and
postoperative hemoglobin levels: results of a secondary analysis of
a prospective observational study. Front Cardiovasc Med.
11(1459268)2024.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Verras GI and Mulita F:
Butyrylcholinesterase levels correlate with surgical site infection
risk and severity after colorectal surgery: A prospective
single-center study. Front Surg. 11(1379410)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Dimopoulos MP, Verras GI and Mulita F:
Editorial: Newest challenges and advances in the treatment of
colorectal disorders; from predictive biomarkers to minimally
invasive techniques. Front Surg. 11(1487878)2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pandrowala S, Jones RL, Gupta S and Gulia
A: Desmoid fibromatosis: Is the current picture changing? Future
Oncol. 17:3397–3408. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yi Y and Hua L: A case report of colon
aggressive fibromatosis misdiagnosed as ovarian tumor. J Int Obstet
Gynecol. 51:271–273. 2024.
|
|
49
|
Ou J, Su D, Guan Y, Ge L, Deng S, Yan Y,
Hao Y, Lu M, Zhang S and Xie R: Efficacy and safety of systemic
treatment for progressive and refractory desmoid tumor: A
systematic review and Bayesian network meta-analysis. Discov Oncol.
15(619)2024.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yuan M and Han G: Progress in targeted
therapy for aggressive fibromatosis. Chin J Clin Oncol. 48:695–699.
2021.
|
|
51
|
Oh CR, Jeong H, Kim W, Lee JS, Song SY,
Song JS, Cho KJ, Chung HW, Lee MH, Hong JY, et al: Favorable
clinical efficacy of cytotoxic chemotherapy in patients with
progressive desmoid tumors: A retrospective real-world study. Int J
Clin Oncol. 29:853–861. 2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Koike T, Shibata M, Kaneko R, Fujita S,
Akiyama K, Toyama D and Yamamoto S: Efficacy of vinblastine and
methotrexate in a childhood patient with progressive desmoid
fibromatosis of the lower jaw: A case report. Tokai J Exp Clin Med.
49:137–139. 2024.PubMed/NCBI
|
|
53
|
Borovkov A, Orbach D, Bonneau-Lagacherie
J, Carausu L, Guimard G, Haouy S, Jannier S, Pagnier A, Proust S,
Verite C, et al: Desmoid-type fibromatosis tumors in children after
first-line failure: Clinical aspects and approaches for subsequent
therapeutic lines. Pediatr Blood Cancer. 72(e31866)2025.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Fisher C and Thway K: Aggressive
fibromatosis. Pathology. 46:135–140. 2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Gronchi A, Colombo C, Le Péchoux C, Dei
Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali
PG, et al: Sporadic desmoid-type fibromatosis: A stepwise approach
to a non-metastasising neoplasm-a position paper from the Italian
and the French sarcoma group. Ann Oncol. 25:578–583.
2014.PubMed/NCBI View Article : Google Scholar
|
